Physician profile
Stephen A Yu
NPI 1295284834
$456.76
in general payments reported to CMS, 2019-2025
7 companies · $15.42 in 2025
The $15.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.84 · 2021: $13.05 · 2022: $106 · 2023: $81.72 · 2024: $185 · 2025: $15.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $199.61 | 2023-2024 | Gemtesa |
| Array Biopharma INC | $148.69 | 2022-2023 | Lorbrena, Braftovi, Mektovi |
| Dexcom, INC. | $40.57 | 2024-2025 | Dexcom G6 Transmitter |
| Medtronic USA, INC. | $22.72 | 2019 | |
| Eisai INC. | $19.14 | 2019 | |
| Abbvie INC. | $13.05 | 2021 | |
| Lilly USA, LLC | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.